162 related articles for article (PubMed ID: 19101978)
1. The molecular basis of inhibition of Golgi alpha-mannosidase II by mannostatin A.
Kuntz DA; Zhong W; Guo J; Rose DR; Boons GJ
Chembiochem; 2009 Jan; 10(2):268-77. PubMed ID: 19101978
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of the inhibition of Golgi alpha-mannosidase II by mannostatin A and the role of the thiomethyl moiety in ligand-protein interactions.
Kawatkar SP; Kuntz DA; Woods RJ; Rose DR; Boons GJ
J Am Chem Soc; 2006 Jun; 128(25):8310-9. PubMed ID: 16787095
[TBL] [Abstract][Full Text] [Related]
3. Human lysosomal alpha-mannosidases exhibit different inhibition and metal binding properties.
Venkatesan M; Kuntz DA; Rose DR
Protein Sci; 2009 Nov; 18(11):2242-51. PubMed ID: 19722277
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a potent aminocyclitol alpha-mannosidase inhibitor, 1L-(1,2,3,5/4)-5-amino-4-O-methyl-1,2,3,4-cyclopentanetetrol.
Ogawa S; Morikawa T
Bioorg Med Chem Lett; 2000 May; 10(10):1047-50. PubMed ID: 10843213
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Golgi mannosidase II with mannostatin A analogues: synthesis, biological evaluation, and structure-activity relationship studies.
Li B; Kawatkar SP; George S; Strachan H; Woods RJ; Siriwardena A; Moremen KW; Boons GJ
Chembiochem; 2004 Sep; 5(9):1220-7. PubMed ID: 15368573
[TBL] [Abstract][Full Text] [Related]
6. Probing the substrate specificity of Golgi alpha-mannosidase II by use of synthetic oligosaccharides and a catalytic nucleophile mutant.
Zhong W; Kuntz DA; Ember B; Singh H; Moremen KW; Rose DR; Boons GJ
J Am Chem Soc; 2008 Jul; 130(28):8975-83. PubMed ID: 18558690
[TBL] [Abstract][Full Text] [Related]
7. Structural investigation of the binding of 5-substituted swainsonine analogues to Golgi alpha-mannosidase II.
Kuntz DA; Nakayama S; Shea K; Hori H; Uto Y; Nagasawa H; Rose DR
Chembiochem; 2010 Mar; 11(5):673-80. PubMed ID: 20209559
[TBL] [Abstract][Full Text] [Related]
8. Golgi alpha-mannosidase II cleaves two sugars sequentially in the same catalytic site.
Shah N; Kuntz DA; Rose DR
Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9570-5. PubMed ID: 18599462
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of Golgi alpha-mannosidase II inhibitors identified from a focused glycosidase inhibitor screen.
Kuntz DA; Tarling CA; Withers SG; Rose DR
Biochemistry; 2008 Sep; 47(38):10058-68. PubMed ID: 18759458
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of docking programs for predicting binding of Golgi alpha-mannosidase II inhibitors: a comparison with crystallography.
Englebienne P; Fiaux H; Kuntz DA; Corbeil CR; Gerber-Lemaire S; Rose DR; Moitessier N
Proteins; 2007 Oct; 69(1):160-76. PubMed ID: 17557336
[TBL] [Abstract][Full Text] [Related]
11. Mannostatin A, a new glycoprotein-processing inhibitor.
Tropea JE; Kaushal GP; Pastuszak I; Mitchell M; Aoyagi T; Molyneux RJ; Elbein AD
Biochemistry; 1990 Oct; 29(43):10062-9. PubMed ID: 2271638
[TBL] [Abstract][Full Text] [Related]
12. Structure of Golgi alpha-mannosidase II: a target for inhibition of growth and metastasis of cancer cells.
van den Elsen JM; Kuntz DA; Rose DR
EMBO J; 2001 Jun; 20(12):3008-17. PubMed ID: 11406577
[TBL] [Abstract][Full Text] [Related]
13. A versatile approach to the synthesis of (+)-mannostatin A analogues.
Cho SJ; Ling R; Kim A; Mariano PS
J Org Chem; 2000 Mar; 65(5):1574-7. PubMed ID: 10814128
[No Abstract] [Full Text] [Related]
14. Structure, mechanism and inhibition of Golgi α-mannosidase II.
Rose DR
Curr Opin Struct Biol; 2012 Oct; 22(5):558-62. PubMed ID: 22819743
[TBL] [Abstract][Full Text] [Related]
15. Manno-
Armstrong Z; Kuo CL; Lahav D; Liu B; Johnson R; Beenakker TJM; de Boer C; Wong CS; van Rijssel ER; Debets MF; Florea BI; Hissink C; Boot RG; Geurink PP; Ovaa H; van der Stelt M; van der Marel GM; Codée JDC; Aerts JMFG; Wu L; Overkleeft HS; Davies GJ
J Am Chem Soc; 2020 Jul; 142(30):13021-13029. PubMed ID: 32605368
[TBL] [Abstract][Full Text] [Related]
16. N-Benzyl Substitution of Polyhydroxypyrrolidines: The Way to Selective Inhibitors of Golgi α-Mannosidase II.
Šesták S; Bella M; Klunda T; Gurská S; Džubák P; Wöls F; Wilson IBH; Sladek V; Hajdúch M; Poláková M; Kóňa J
ChemMedChem; 2018 Feb; 13(4):373-383. PubMed ID: 29323461
[TBL] [Abstract][Full Text] [Related]
17. Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II alpha-mannosidases demonstrates different saccharide distortions in inverting and retaining catalytic mechanisms.
Shah N; Kuntz DA; Rose DR
Biochemistry; 2003 Dec; 42(47):13812-6. PubMed ID: 14636047
[TBL] [Abstract][Full Text] [Related]
18. 1,4-Dideoxy-1,4-imino-D- and L-lyxitol-based inhibitors bind to Golgi α-mannosidase II in different protonation forms.
Kóňa J; Šesták S; Wilson IBH; Poláková M
Org Biomol Chem; 2022 Nov; 20(45):8932-8943. PubMed ID: 36322142
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of modified D-mannose core derivatives and their impact on GH38 α-mannosidases.
Poláková M; Horák R; Šesták S; Holková I
Carbohydr Res; 2016 Jun; 428():62-71. PubMed ID: 27152630
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of the glycosylation step catalyzed by Golgi alpha-mannosidase II: a QM/MM metadynamics investigation.
Petersen L; Ardèvol A; Rovira C; Reilly PJ
J Am Chem Soc; 2010 Jun; 132(24):8291-300. PubMed ID: 20504027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
